ABCL · AbCellera Biologics Inc. · Documents

$11.07 -0.37 (-3.23%)

Market Cap

$3.50B

306.61M

The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.

Type	Filing Date	Period
8-K	2026-08-13	2026-08-12
8-K	2026-08-10	—
8-K	2026-08-07	—
8-K	2026-08-05	—
10-Q	2026-08-05	2026-06-30
8-K	2026-07-29	—
8-K	2026-07-06	2026-06-30
8-K	2026-06-17	—
8-K	2026-06-12	2026-06-11
8-K	2026-06-05	2026-06-01
Investor Event Transcript	2026-06-04	2026-06-30
10-Q	2026-05-11	2026-03-31
8-K	2026-05-11	—
DEF 14A	2026-04-29	2025-12-31
Investor Event Transcript	2026-04-21	2026-06-30
10-K	2026-02-24	2025-12-31
8-K	2026-02-24	—
8-K	2026-01-14	2026-01-12
8-K	2025-12-18	—
8-K	2025-11-28	2025-11-24
8-K	2025-11-12	2025-11-10
10-Q	2025-11-06	2025-09-30
8-K	2025-11-06	—
8-K	2025-09-10	—
8-K	2025-08-07	—
10-Q	2025-08-07	2025-06-30
8-K	2025-06-13	2025-06-12
8-K	2025-05-30	—
8-K	2025-05-14	—
8-K	2025-05-13	2025-05-12
10-Q	2025-05-08	2025-03-31
8-K	2025-05-08	—
DEF 14A	2025-04-29	2024-12-31
10-K	2025-02-27	2024-12-31
8-K	2025-02-27	—
8-K	2025-02-18	—
8-K	2024-11-04	—
10-Q	2024-11-04	2024-09-30
8-K	2024-08-06	—
10-Q	2024-08-06	2024-06-30
8-K	2024-06-13	—
10-Q	2024-05-07	2024-03-31
8-K	2024-05-07	—
DEF 14A	2024-04-29	2023-12-31
8-K	2024-02-23	2024-02-16
10-K	2024-02-20	2023-12-31
8-K	2024-02-20	—
8-K	2023-11-28	—
10-Q	2023-11-02	2023-09-30
8-K	2023-11-02	—

Showing 1–50 of 95 filings

Key facts CIK 1703057 CUSIP 00288U106 13F (30d) 89 filings 89 filers Visit website Investor relations